Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation
Warfarin, Rivaroxaban, and Dabigatran can effectively prevent thrombosis in elderly patients with atrial fibrillation, with Rivaroxaban and Dabigatran showing superior effectiveness. All three drugs demonstrated similar low rates of bleeding events and had no significant impact on coagulation and liver function.
Authors
- Chong Cheng (ORCID: https://orcid.org/0000-0002-6872-2240)
- Huiqun Tan
- Cheng Chen (ORCID: https://orcid.org/0000-0002-4078-0182)
- Qing Tian (ORCID: https://orcid.org/0000-0003-2795-363X)
- Mengyun Feng
- Qian Zhou (ORCID: https://orcid.org/0009-0000-3193-2618)
- Xixin Ji
Institutions
- Hubei Polytechnic University (CN)
- Huangshi Central Hospital (CN)
Publication Details
- Journal
- Clinical Cardiology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/clc.70014
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.40